BlackRock’s DiaMedica Therapeutics DMAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.65M Buy
1,191,813
+1,085,463
+1,021% +$4.23M ﹤0.01% 3734
2025
Q1
$403K Sell
106,350
-1,530
-1% -$5.8K ﹤0.01% 4406
2024
Q4
$586K Buy
107,880
+90
+0.1% +$489 ﹤0.01% 4316
2024
Q3
$452K Buy
107,790
+2,487
+2% +$10.4K ﹤0.01% 4302
2024
Q2
$311K Buy
105,303
+1,933
+2% +$5.7K ﹤0.01% 4401
2024
Q1
$286K Sell
103,370
-1,362
-1% -$3.77K ﹤0.01% 4454
2023
Q4
$297K Buy
104,732
+3,007
+3% +$8.54K ﹤0.01% 4469
2023
Q3
$262K Buy
101,725
+29,810
+41% +$76.9K ﹤0.01% 4535
2023
Q2
$311K Buy
71,915
+245
+0.3% +$1.06K ﹤0.01% 4535
2023
Q1
$110K Buy
71,670
+1,733
+2% +$2.65K ﹤0.01% 4851
2022
Q4
$111K Buy
69,937
+1,067
+2% +$1.69K ﹤0.01% 4928
2022
Q3
$85K Buy
68,870
+2,153
+3% +$2.66K ﹤0.01% 5132
2022
Q2
$135K Buy
66,717
+10,278
+18% +$20.8K ﹤0.01% 5055
2022
Q1
$141K Sell
56,439
-2,133
-4% -$5.33K ﹤0.01% 5111
2021
Q4
$219K Buy
58,572
+2,602
+5% +$9.73K ﹤0.01% 5016
2021
Q3
$225K Sell
55,970
-5,289
-9% -$21.3K ﹤0.01% 4889
2021
Q2
$273K Buy
61,259
+1,094
+2% +$4.88K ﹤0.01% 4761
2021
Q1
$551K Buy
60,165
+4,384
+8% +$40.1K ﹤0.01% 4529
2020
Q4
$566K Buy
55,781
+12,008
+27% +$122K ﹤0.01% 4254
2020
Q3
$185K Sell
43,773
-735
-2% -$3.11K ﹤0.01% 4322
2020
Q2
$309K Buy
44,508
+6,135
+16% +$42.6K ﹤0.01% 4206
2020
Q1
$108K Buy
38,373
+6,320
+20% +$17.8K ﹤0.01% 4264
2019
Q4
$156K Buy
32,053
+6,441
+25% +$31.3K ﹤0.01% 4302
2019
Q3
$53K Sell
25,612
-1,463
-5% -$3.03K ﹤0.01% 4477
2019
Q2
$134K Buy
27,075
+16,651
+160% +$82.4K ﹤0.01% 4371
2019
Q1
$47K Buy
+10,424
New +$47K ﹤0.01% 4435